Some oncologists are turning to GLP-1 agents to help patients shed excess pounds, with the goal of improving cancer outcomes.

WW International announced Friday that CEO Sima Sistani would leave her role effective immediately. Tara Comonte, a ...

FDA-authorized alternatives to brand-name weight loss medications gain traction, offering cheaper options for patients.

Roche told investors on Monday that it plans to make significant cuts to both the cost and time it takes for it to develop ...

Eli Lilly is considering testing its blockbuster weight-loss drugs in people who are not overweight but are at risk of weight ...

Clinton warns of October surprise that will ‘distort and pervert’ Harris ...

The startup will be headed by CEO Ron Renaud, who previously led Cerevel Therapeutics — a developer of drugs for neurological conditions — and oversaw its acquisition by AbbVie in an $8.7 billion deal ...

A series of state and federal lawsuits challenging coverage exclusions for obesity drugs and procedures are testing the ...

Sima Sistani, who took up the CEO post at WW International two-and-a-half years ago, is out, according to the company.

GLP-1 medications—like Ozempic, Wegovy, and Zepbound—can help you shed pounds, but only if taken properly. Don't get caught ...

Maez Waibel lost more than 30 pounds in nine months on the new weight-loss drugs, sparking a substantial improvement in health. But instead of feeling happy and relieved, Waibel’s days have been ...